发明名称 NITROGEN-CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF ATRIAL FIBRILLATION
摘要 The present invention provides a novel diazepine compound that blocks the IKur current or the Kv1.5 channel potently and more selectively than other K+ channels. The present invention relates to a diazepine compound represented by General Formula (1);or a salt thereof,wherein R1, R2, R3, and R4 are each independently hydrogen, lower alkyl, cyclo lower alkyl or lower alkoxy lower alkyl;R2 and R3 may be linked to form lower alkylene;A1 is lower alkylene optionally substituted with one or more substituents selected from the group consisting of hydroxyl and oxo;Y1 and Y2 are each independently —N═ or —CH═;andR5 is group represented by;wherein R6 and R7 are each independently hydrogen or organic group;R6 and R7 may be linked to form a ring together with the neighboring group —XA—N—XB—;XA and XB are each independently a bond, lower alkylene, etc.
申请公布号 US2014343278(A1) 申请公布日期 2014.11.20
申请号 US201414314189 申请日期 2014.06.25
申请人 OTSUKA PHARMACEUTICAL CO., LTD. 发明人 OSHIMA Kunio;MATSUMURA Shuuji;YAMABE Hokuto
分类号 C07D491/048;C07D401/14;C07D409/14;C07D401/12;C07D413/14;C07D243/12;C07D417/12;C07D403/12;C07D405/14;C07D417/14 主分类号 C07D491/048
代理机构 代理人
主权项 1. A benzodiazepine compound represented by General Formula (1): or a salt thereof, wherein R1, R2, R3, and R4 are each independently hydrogen or lower alkyl; R2 and R3 may be linked to form lower alkylene; A1 is lower alkylene optionally substituted with one or more hydroxyls; and R5 is an aryl or heterocyclic group, each of which is optionally substituted.
地址 Tokyo JP